Aarti Pharmalabs ne Gujarat High Court ka darwaza khatkhataya hai. Company ne Superintendent of Stamps dwara maangi gayi **₹59.50 Cr** ki penalty aur stamp duty ke order ko challenge kiya hai.
Kya hua hai pura mamla?
Aarti Pharmalabs ne Gujarat High Court mein ek writ petition daali hai. Ye pura mamla August 29, 2026 ko aaye us order se juda hai, jismein Superintendent of Stamps ne company se ₹59.50 Crore ki bhari-bharkam penalty aur stamp duty maangi thi.
NCLT aur Demerger ka connection
Ye demand purane demerger scheme se judi hai, jise September 21, 2022 ko NCLT Ahmedabad Bench ne approve kiya tha. Ab company is extra levy ke khilaaf court se raahat maang rahi hai. Agar faisla company ke favor mein nahi raha, toh ₹59.50 Crore ka seedha cash outflow ho sakta hai, jo company ki balance sheet par thoda pressure daal sakta hai.
Investors ke liye alert
Abhi court case chal raha hai, aur legal matters mein kuch bhi kehna jaldbazi hogi. Investors ko advice hai ki woh company ke aane wale quarterly reports par nazar rakhein ki kya unhone is potential liability ke liye koi provision rakha hai ya nahi. Filhal, High Court ke agle order ka intezar rahega.